Well, I didn't exactly get my Pacific Biosciences preview out before their J.P. Morgan presentation. Luckily, the slides for that primarily projected financials and touted their successes -- and didn't drop any major platform announcements in -- so I didn't miss out. PacBio's position is important and worth reviewing, even if it doesn't change much.
Tuesday, January 09, 2018
Illumina CEO Francis deSouza's J.P. Morgan Presentation did not disappoint. While humdrum financials and touting market dominance and areas of future growth came first, then came the big Firefly announcement (with a name change to iSeq 100) -- and then after another short spell of reviewing the latest Nextera chemistry came a smaller bombshell -- Illumina is partnering with former arch-rival Thermo Fisher (nee Life Technologies nee Applied Biosystems) to move the AmpliSeq multiplex PCR technology over to the Illumina platform.
Sunday, January 07, 2018
Tuesday, January 02, 2018
Time to start gazing into my cloudy liquid crystal ball and attempt to see what will happen in the sequencing world in 2018. J.P. Morgan is next week, which puts a time box on getting predictions out. One thing I see on both my personal and blogging horizon are flying creatures bearing light. On the local front, TNG has decided to head this fall to the City of Brotherly Love to learn to fly and breath flame. But in the sequencing world -- well, I'm going to need to pack a huge Ball jar for my trip to AGBT this year, as I plan to hunt out a Firefly.
Monday, January 01, 2018
A new year beckons and with it a burst of enthusiasm for writing. Which also means combing through post ideas from last year that never quite were completed -- some as stubs or at least headlines. But before tackling the new, I feel I need to tackle some personal losses in 2017.